Latest Blogs

Dec 08, 2022
ASCO’s delegation to the American Medical Association’s House of Delegates (AMA HOD) recently traveled to Honolulu for the Interim meeting. Our resolutions primarily focused on the threat of legislation that could criminalize medically necessary care in the wake of the Supreme Court’s decision...
Nov 28, 2022
I began my medical career in Arizona, where I received an early lesson in the importance of cultural sensitivity thanks to members of the Navajo Nation from the Four Corners region.
Nov 17, 2022
After two years of limited activity during the COVID-19 pandemic, October Breast Cancer Awareness Month returned in 2022 with a variety of traditional and innovative activities worldwide.
Nov 10, 2022
"Cancer research relevant to LMICs is a necessity, not a luxury," writes Dr. Khalid El Bairi, and early-career oncologists in LMIC settings can advance cancer research in their communities.
Subscribe to this column

Guest Commentary

Guest Commentary on ASCOconnection.org provides an interactive platform for leaders in their respective fields to share timely perspectives on oncology topics. If you are an ASCO member interested in contributing a guest post, please contact ascoconnection@asco.org.

Nov 07, 2019
After observing Health Care Quality Week, Dr. Aakash Desai and Dr. Devika Das ask, "What does quality really mean to us, especially in oncology?"
Nov 04, 2019
Dr. Arjun Gupta pens a heartfelt tribute to Dr. David H. Johnson in honor of Dr. Johnson's induction as a 2019 Giant of Cancer Care and his many years of mentorship.
Nov 01, 2019
ASCO Nominating Committee chair Dr. Cora N. Sternberg encourages all eligible members to cast their votes for future leaders of ASCO.
Oct 22, 2019
In an increasingly challenging research funding climate, partnerships to share resources and leverage complementary expertise have never been more important, writes Mr. Michael Burton.
Aug 07, 2019
Does big data have a big problem? Dr. John W. Sweetenham cautions, "There is a real danger that we legitimize flawed data sets by labelling them as 'real-world data' when they neither reflect the real world nor can we trust the data."
Aug 05, 2019
Patient advocate Martha E. "Meg" Gaines poses six essential questions for patient-provider teams to consider in their discussions about targeted therapies.

Pages